Clinical Trial Update: Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/2 clinical trial of XNW28012 for advanced solid tumors, including pancreatic cancer, with recruiting ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• XNW28012

Snippet

Sponsor: Evopoint Biosciences Inc. | Conditions: Advanced Solid Tumors, Pancreatic Carcinoma | Phase 1, Phase 2 | Status: RECRUITING